• Markets
    • icon
  • Companies
MDR · ASX

MedAdvisor Limited (ASX:MDR)

AU$0.54

 -0.005 (-0.926%)
ASX:Live
26/07/2024 04:10:15 PM
Recent Earnings upgrade Hammer Bullish HALO Price Momentum HALO Ords GROWTH AUS +2
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

MDR Overview

MDR Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Weak

Earnings

Very Strong

Growth

Earnings

Neutral

Dividends

Very Strong

Quality

Capital Efficiency

Strong

Balance Sheet

Very Strong

About MDR

Website

MedAdvisor Limited

Telephone

61.3.9095.3036

Address

Level 2 971 Burke Road Camberwell, Victoria (VIC) 3124

Description

MedAdvisor Ltd. engages in the provision of pharmacy-driven, innovative patient engagement solutions that simplify the patient medication journey to empower better health. It operates through the following segments: Australia and New Zealand Operations, the United States Operations, the United Kingdom Operations, Asia Operations, and Corporate. The company was founded by Joshua Swinnerton in 2010 and is headquartered in Camberwell, Australia.

MDR Price Chart

Key Stats

Market Cap

AU$291.79M

PE

55.40

EV/EBITDA

15.9

Dividends Overview

DIV Yield

.0%

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.16 - 0.59

Trade Value (12mth)

AU$53,551.00

1 week

0%

1 month

10.2%

YTD

145.45%

1 year

140%

All time high

1.73

Key Fundamentals

EPS 3 yr Growth

-48.900%

EBITDA Margin

-2.40%

Operating Cashflow

-$1m

Free Cash Flow Return

-2.80%

ROIC

-21.90%

Interest Coverage

-1.10

Quick Ratio

0.80

Other Data

Shares on Issue (Fully Dilluted)

596m

HALO Sector

Technology

Next Company Report Date

29-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

MDR Announcements

Latest Announcements

Date Announcements

25 July 24

Q4 FY24 MDR Quarterly Update

×

Q4 FY24 MDR Quarterly Update

19 July 24

Release from Escrow

×

Release from Escrow

04 July 24

Change in substantial holding

×

Change in substantial holding

03 July 24

Becoming a substantial holder from EBO

×

Becoming a substantial holder from EBO

03 July 24

EBO: MedAdvisor Update

×

EBO: MedAdvisor Update

13 June 24

Application for quotation of securities - MDR

×

Application for quotation of securities - MDR

04 June 24

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

22 May 24

MDR Record FY24 Performance with Positive EBITDA and NPAT

×

MDR Record FY24 Performance with Positive EBITDA and NPAT

13 May 24

Application for quotation of securities - MDR

×

Application for quotation of securities - MDR

23 April 24

Q3 FY24 MDR Quarterly Update

×

Q3 FY24 MDR Quarterly Update

17 April 24

Change in substantial holding

×

Change in substantial holding

17 April 24

Change in substantial holding

×

Change in substantial holding

08 April 24

Application for quotation of securities - MDR

×

Application for quotation of securities - MDR

27 March 24

MDR - ASX Small and Mid-Cap Conference March 2024

×

MDR - ASX Small and Mid-Cap Conference March 2024

06 March 24

Application for quotation of securities - MDR

×

Application for quotation of securities - MDR

01 March 24

MDR 1H FY24 Investor Webinar Recording

×

MDR 1H FY24 Investor Webinar Recording

29 February 24

MDR Appendix 4D and FY24 Half Year Report

×

MDR Appendix 4D and FY24 Half Year Report

29 February 24

MDR FY24 Half Year Investor Presentation

×

MDR FY24 Half Year Investor Presentation

29 February 24

MDR FY24 Half Year Results Update

×

MDR FY24 Half Year Results Update

28 February 24

MDR and BEN partner to bring conversational AI to patients

×

MDR and BEN partner to bring conversational AI to patients

19 February 24

MedAdvisor 1H FY24 Investor Webinar

×

MedAdvisor 1H FY24 Investor Webinar

16 February 24

Becoming a substantial holder

×

Becoming a substantial holder

30 January 24

Q2 FY24 MDR Quarterly Update

×

Q2 FY24 MDR Quarterly Update

15 January 24

Application for quotation of securities - MDR

×

Application for quotation of securities - MDR

29 November 23

Notification regarding unquoted securities - MDR

×

Notification regarding unquoted securities - MDR

MDR Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.04 -0.05 -0.02 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.04 -0.05 -0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock -8.4 -4.1 54.7 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A 55.4 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A 15.9 Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.02 -0.03 -0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.04 -0.00 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 42.7 -61.9 74.0 Lock Lock Lock
     Yield % Lock Lock Lock Lock -13.6 -0.9 -1.2 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.13 0.09 0.11 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock -0.02 -0.06 -0.04 Lock Lock Lock
     Growth % Lock Lock Lock Lock -135.4 -254.3 28.9 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 317 378 545 Lock Lock Lock
Basic m Lock Lock Lock Lock 317 378 545 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 39 68 98 Lock Lock Lock
     Growth % Lock Lock Lock Lock 303.8 74.7 44.6 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 12 14 20 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -6 -2 13 Lock Lock Lock
     Growth % Lock Lock Lock Lock -66.8 69.6 783.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -15.6 -2.7 12.8 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 116 103 87 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -15 -11 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock -42.2 25.2 79.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock -38.9 -16.7 -2.4 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 3 5 5 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -18 -16 -8 Lock Lock Lock
     Growth % Lock Lock Lock Lock -64.5 11.6 52.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -47.2 -23.9 -7.9 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -19 -18 -11 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -4 0 1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -14 -17 -11 Lock Lock Lock
     Growth % Lock Lock Lock Lock -45.5 -24.4 34.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -36.0 -25.6 -11.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -13 0 -1 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -43 0 -3 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 51 2 12 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -13 -1 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock -47.3 95.8 -197.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.3 -0.0 -0.0 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 7 8 14 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 81 78 96 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 8 8 12 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock 2 6 -1 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 32 44 47 Lock Lock Lock
Equity $m Lock Lock Lock Lock 48 35 48 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 56 43 61 Lock Lock Lock
     Growth % Lock Lock Lock Lock 214.5 -24.2 43.0 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -17.2 -22.1 -11.8 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -28.8 -50.2 -23.3 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -47.9 -30.6 -14.1 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -37.8 -35.2 -21.9 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -34.0 -0.5 -2.8 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -35.8 -7.3 -1.1 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -0.1 -0.5 0.5 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock 4.1 16.9 -2.3 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 0.9 0.5 0.8 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 0.9 0.5 0.8 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 33.5 41.0 50.5 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -53.9 -0.7 -4.4 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 5.4 6.3 9.4 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 9.8 8.9 4.3 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.5 0.9 1.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.5 0.9 1.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -47.9 -26.2 -10.7 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -22.9 -22.6 -11.0 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -17.2 -22.1 -11.8 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.7 2.3 2.0 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -28.8 -50.2 -23.3 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -28.8 -50.2 -23.3 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 67.3 58.0 38.7 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 67.3 58.0 38.7 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 18.3 25.7 21.7 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 49.0 32.3 17.0 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

.0%

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

MDR Shortsell

Frequently Asked Questions

The current share price of MedAdvisor Limited (MDR:ASX) is AU$0.54.
The 52-week high share price for MedAdvisor Limited (MDR:ASX) is AU$0.59.
The 52-week low share price for MedAdvisor Limited (MDR:ASX)? is AU$0.16.
The current TTM dividend payout for MedAdvisor Limited (MDR:ASX) is 0.00.
MedAdvisor Limited (MDR:ASX) does not pay a dividend.
MedAdvisor Limited (MDR:ASX) has a franking level of 0.0%.
MedAdvisor Limited (MDR:ASX) is classified in the Technology.
The current P/E ratio for MedAdvisor Limited (MDR:ASX) is 55.40.
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.